Our Department

Department Alumni Fest 2016

Our Department

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

User menu

You are here

  1. Department of Statistics
  2. Our Department
  3. People Directory
  4. Publications

Publications by John Petkau

2004

Vedal S, Rich K, Brauer M, White R, Petkau J. Air pollution and cardiac arrhythmias in patients with implantable cardioverter defibrillators. Inhalation Toxicology. Taylor & Francis; 2004;16:353–362.
Rich KE, Petkau J, Vedal S, Brauer M. A case-crossover analysis of particulate air pollution and cardiac arrhythmia in patients with implantable cardioverter defibrillators. Inhalation Toxicology. Taylor & Francis; 2004;16:363–372.

2003

Polman CH, Kappos L, Petkau J, Thompson A. Neutralising antibodies to interferon beta during the treatment of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry. 2003;74:1162.
Polman C, Kappos L, White R, Dahlke F, Beckmann K, Pozzilli C, et al. Neutralising antibodies during treatment of secondary progressive multiple sclerosis with interferon beta-1b. Neurology. 2003;61:1025.
Polman C, Kappos L, White R, Dahlke F, Beckmann K, Pozzilli C, et al. Neutralizing antibodies during treatment of secondary progressive multiple sclerosis with interferon β-1b. Neurology. AAN Enterprises; 2003;60:37–43.
Vedal S, Brauer M, White R, Petkau J. Air pollution and daily mortality in a city with low levels of pollution. Environmental Health Perspectives. National Institute of Environmental Health Science; 2003;111:45-51.
Petkau AJ. Optimal group sequential designs for the Anscombe-Colton model. In Mathematical Statistics and Applications: Festschrift for Constance van Eeden. IMS Lecture Notes - Monograph Series; 2003. pp. 291–315.
Petkau AJ. Statistical approaches to assessing the effects of neutralizing antibodies IFNβ-1b in the pivotal trial of relapsing-remitting multiple sclerosis. Neurology. AAN Enterprises; 2003;61:Supplement 5:S35–S37.

2002

Brauer M, Brumm J, Vedal S, Petkau AJ. Exposure misclassification and threshold concentrations in time series analyses of air pollution health effects. Risk Analysis. Wiley Online Library; 2002;22:1183–1193.

2001

Brauer M, Ebelt ST, Fisher TV, Brumm J, Petkau AJ, Vedal S. Exposure of chronic obstructive pulmonary disease patients to particles: Respiratory and cardiovascular health effects. Journal of Exposure Analysis and Environmental Epidemiology. 2001;11:490-500.

2000

Ebelt ST, Petkau AJ, Vedal S, Fisher TV, Brauer M. Exposure of chronic obstructive pulmonary disease patients to particulate matter: Relationships between personal and ambient air concentrations. Journal of the Air and Waste Management Association. Taylor & Francis; 2000;50:1081–1094.
Paszner B, Petkau J, Oger J. Impact of antibodies to interferon-β during treatment of multiple sclerosis. In Drug Treatment of Multiple Sclerosis. Auckland: Adis International; 2000. pp. 89–108.

1999

Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, et al. Natural killer cells in relapsing-remitting multiple sclerosis: the effect of treatment with interferon β-1B. Neurology. AAN Enterprises; 1999;52:351–359.
Paszner B, Petkau J, Oger J. Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?. CNS Drugs. Springer; 1999;11:225–243.
Cover KS, Petkau J, Li DKB, Paty DW. Lesion load reproducibility and statistical sensitivity of clinical trials in multiple sclerosis. Neurology. 1999;52:433-434.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trials outcome measure. Brain. Oxford Univ Press; 1999;122:871–882.
Bajorski P, Petkau AJ. Nonparametric two-sample comparisons of changes on ordinal responses. Journal of the American Statistical Association. Taylor & Francis; 1999;94:970–978.

1998

Vedal S, Petkau J, White R, Blair J. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. American Journal of Respiratory and Critical Care Medicine. Am Thoracic Soc; 1998;157:1034–1043.
Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, et al. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. Journal of Neuroimmunology. Elsevier; 1998;86:123–133.
Petkau AJ. Statistical methods for evaluating multiple sclerosis therapies. Seminars in Neurology. 1998;18:351–375.

1997

D'yachkova Y, Petkau J, Whtie R. Longitudinal analyses for magnetic resonance imaging outcomes in multiple sclerosis clinical trials. Journal of Biopharmaceutical Statistics. Taylor & Francis; 1997;7:501–531.
Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, et al. Recommendations from the National Multiple Sclerosis Society clinical outcomes assessment task force. Annals of Neurology. Wiley Online Library; 1997;42:379–382.

1996

Le ND, Petkau AJ, Rosychuk R. Surveillance of clustering near point sources. Statistics in Medicine. Wiley Online Library; 1996;15:727–740.
Petkau AJ. Statistical and design considerations for multiple sclerosis clinical trials. In Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives. London: Springer-Verlag; 1996. pp. 63–103.
Rudick R, Fischer J, Antel J, Confavreux C, Cutter G, Ellison G, et al. Clinical outcomes assessment in multiple sclerosis. Annals of Neurology. Wiley Online Library; 1996;40:469–479.

1995

Johnson DL, Petkau AJ. A likelihood ratio test for equality of deviations from randomness. Researches on Population Ecology. Springer; 1995;37:203–209.

1994

Graham J, Petkau AJ. Spatial association learning in hummingbirds. In Case Studies in Biometry. New York: John Wiley & Sons; 1994. pp. 159-187.
McNeney B, Petkau AJ. Overdispersed Poisson regression models for studies of air pollution and human health. Canadian Journal of Statistics. Wiley Online Library; 1994;22:421–440.

1993

Paty DW, Koopmans RA, Zhao GJ, Li DKB, Oger JJF, Petkau J. Magnetic resonance imaging (MRI) as an outcome measure in multiple sclerosis. Journal of Neurological Rehabilitation. SAGE Publications; 1993;7:117–129.

1990

Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology. AAN Enterprises; 1990;40:479–486.
Li B, Petkau AJ. A regression model with random effects for beer chemistry and Canadians' beer preferences. Canadian Journal of Statistics. Wiley Online Library; 1990;18:108–121.

1989

Bather JA, Chernoff H, Petkau AJ. The effect of truncation on a sequential test for the drift of Brownian motion. Sequential Analysis. Taylor & Francis; 1989;8:169–190.
Petkau AJ, Sitter RR. Models for quantal response experiments over time. Biometrics. JSTOR; 1989;45:1299–1308.

1988

Le DN, Petkau AJ. The variability of rainfall acidity revisited. Canadian Journal of Statistics. JSTOR; 1988;16:15–38.
Koziol JA, Petkau AJ, Taetle R. Objective criteria for in-vitro responses in human tumor colony-forming assays. Medical Decision Making. SAGE Publications; 1988;8:304–309.

1987

Petkau AJ. Truncated sequential medical trials involving paired data. Canadian Journal of Statistics. Wiley Online Library; 1987;15:363–374.

1986

Chernoff H, Petkau AJ. Numerical solutions for Bayes sequential decision problems. SIAM Journal on Scientific and Statistical Computing. SIAM; 1986;7:46–59.

1985

Chernoff H, Petkau AJ. Sequential medical trials with ethical cost. In Proceedings of the Berkeley Conference in Honor of Jerzy Neyman and Jack Kiefer. Monterey: Wadsworth; 1985. pp. 521-538.
Coté CJ, Petkau AJ. Thiopental requirements may be increased in children re-anesthetized at least one year after recovery from extensive thermal injury. Anesthesia and Analgesia. LWW; 1985;64:1156–1160.

1984

Koziol JA, Petkau AJ. Relative efficiencies of goodness-of-fit procedures with truncated data. Canadian Journal of Statistics. Wiley Online Library; 1984;12:107–117.

1983

Michelassi F, Castorena G, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, et al. Effects of leukotrienes B4 and C4 on coronary circulation and myocardial contractility. Surgery. 1983;94:267–275.
Coté CJ, Petkau AJ, Ryan JF, Welch JP. Wasted ventilation measured in vitro with eight anesthetic circuits with and without inline humidification. Anesthesiology. 1983;59:442–446.

1982

Michelassi F, Landa L, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, et al. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science. American Association for the Advancement of Science; 1982;217:841–843.
Harris ST, Neer RM, Segre GV, Petkau AJ, TULLY GL, Daly M, et al. Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease. Journal of Clinical Endocrinology and Metabolism. The Endocrine Society; 1982;55:1100–1107.

1981

Chernoff H, Petkau AJ. Sequential medical trials involving paired data. Biometrika. Biometrika Trust; 1981;68:119–132.
Joe H, Koziol JA, Petkau AJ. Comparison of procedures for testing the equality of two survival distributions. Biometrics. JSTOR; 1981;37:327–340.
Olkin I, Petkau AJ, Zidek JV. A comparison of n-estimators for the binomial distribution. Journal of the American Statistical Association. Taylor & Francis; 1981;76:637–642.

1980

Petkau AJ. Frequentist properties of three stopping rules for comparative clinical trials. Biometrika. Biometrika Trust; 1980;67:690–692.

1979

Petkau AJ. On a life testing problem involving the two parameter exponential distribution. Communications in Statistics-Theory and Methods. Taylor & Francis; 1979;A8:1523–1534.
Petkau AJ. An application of dynamic programming in statistics. In Dynamic Programming and its Applications. New York: Academic Press; 1979. pp. 221-232.

Pages